X-ray price war in the US hits Nycomed Amersham's half-year
This article was originally published in Clinica
Executive Summary
Price pressures in European X-ray markets, together with lower prices in the US X-ray contrast media markets, depressed Nycomed Amersham's results for the first six months of this year.